Publication:
Bilateral acute onset myopia and angle closure glaucoma after oral topiramate: A case report

dc.contributor.authorBoonyaleephan S.
dc.date.accessioned2021-04-05T04:31:56Z
dc.date.available2021-04-05T04:31:56Z
dc.date.issued2008
dc.date.issuedBE2551
dc.description.abstractObjective: Describe bilateral acute onset myopia and angle-closure glaucoma as ocular adverse effects of topiramate. Case Report: A 23 year-old woman developed bilateral severe blurred vision seven days after initiating therapy with topiramate. Her visual acuity was counting fingers in both eyes. Intraocular pressures were 33 mmHg and 32 mmHg in the right and left eyes, respectively, with conjunctival chemosis, corneal edema, shallow anterior chambers, and closed angles. Her refraction was -7.50 diopters in both eyes. The symptoms and clinical findings resolved completely upon discontinuation of topiramate and administration of antiglaucoma drugs. Conclusion: Topiramate use can result in acute bilateral angle-closure glaucoma and myopia, which are usually reversible upon cessation of the drug. Visual outcome is usually good and the episode resolves within a few weeks. Thus, it is important for clinicians to recognize these conditions and educate patients about these serious adverse effects when prescribing topiramate.
dc.format.mimetypeapplication/pdf
dc.identifier.citationJournal of the Medical Association of Thailand. Vol 91, No.12 (2008), p.1904-1908
dc.identifier.issn1252208
dc.identifier.other2-s2.0-58949090429
dc.identifier.urihttps://hdl.handle.net/20.500.14740/3760
dc.rights.holderScopus
dc.subject.otherAcetazolamide
dc.subject.otherAmitriptyline
dc.subject.otherAntiglaucoma agent
dc.subject.otherGlycerol
dc.subject.otherMefenamic acid
dc.subject.otherPrednisolone acetate
dc.subject.otherPropranolol derivative
dc.subject.otherTimolol maleate
dc.subject.otherTopiramate
dc.subject.otherAcetazolamide
dc.subject.otherAnticonvulsive agent
dc.subject.otherAntihypertensive agent
dc.subject.otherCryoprotective agent
dc.subject.otherDrug derivative
dc.subject.otherFructose
dc.subject.otherGlycerol
dc.subject.otherTimolol
dc.subject.otherTopiramate
dc.subject.otherAdult
dc.subject.otherAnterior eye chamber
dc.subject.otherArticle
dc.subject.otherBiomicroscopy
dc.subject.otherBlurred vision
dc.subject.otherCase report
dc.subject.otherChemosis
dc.subject.otherClosed angle glaucoma
dc.subject.otherCornea edema
dc.subject.otherDrug withdrawal
dc.subject.otherEye examination
dc.subject.otherEye pain
dc.subject.otherEye refraction
dc.subject.otherFemale
dc.subject.otherHuman
dc.subject.otherIntraocular pressure
dc.subject.otherMigraine
dc.subject.otherMyopia
dc.subject.otherPhotography
dc.subject.otherSide effect
dc.subject.otherVisual acuity
dc.subject.otherAcute disease
dc.subject.otherChemically induced disorder
dc.subject.otherClosed angle glaucoma
dc.subject.otherDrug effect
dc.subject.otherMyopia
dc.subject.otherRisk factor
dc.subject.otherAcetazolamide
dc.subject.otherAcute Disease
dc.subject.otherAdult
dc.subject.otherAnticonvulsants
dc.subject.otherAntihypertensive Agents
dc.subject.otherCryoprotective Agents
dc.subject.otherFemale
dc.subject.otherFructose
dc.subject.otherGlaucoma, Angle-Closure
dc.subject.otherGlycerol
dc.subject.otherHumans
dc.subject.otherIntraocular Pressure
dc.subject.otherMyopia
dc.subject.otherRisk Factors
dc.subject.otherTimolol
dc.titleBilateral acute onset myopia and angle closure glaucoma after oral topiramate: A case report
dc.typeArticle
dspace.entity.typePublication
swu.datasource.scopushttps://www.scopus.com/inward/record.uri?eid=2-s2.0-58949090429&partnerID=40&md5=2fd3b1ec03ed2ea01f81dd35fadb3257

Files